Status | Study |
Recruiting |
Study Name: Estimation of Myocardial Iron Overload by 3 Tesla MRI in HFE Hereditary Haemochromatosis Condition: Myocardial Iron Overload HFE-Associated Hereditary Hemochromato Date: 2014-03-21 Interventions: Device: 3Tesla cardiac MRI Device: Electro |
Completed |
Study Name: Retrospective Evaluation of Adult and Pediatric Transfusion-dependent Patients Treated With Deferasirox Therapy Condition: Iron Overload Date: 2013-05-26 |
Terminated |
Study Name: Pharmacokinetics of SSP-004184 in the Treatment of Chronic Iron Overload Requiring Chelation Therapy Condition: Iron Overload Due to Repeated Red Blood Cell Transfusions Date: 2012-05-22 Interventions: Drug: SPD602 50 mg/kg/day orally twice daily for 24 weeks |
Terminated |
Study Name: Rare Iron Overloads Except C282Y Homozygosity : Description and Characterization. Condition: Rare Iron Overloads Except C282Y Homozygosity Date: 2012-02-24 |
Completed |
Study Name: Safety and Efficacy of Desferasirox in Chinese Patients With Iron Overload and Aplastic Anemia Condition: Iron Overload Date: 2011-11-10 Interventions: Drug: Desferasirox Initial Dose: 20 mg/kg/d. Dose modification according to protocol. |
Completed |
Study Name: Amlodipine in the Prevention and Treatment of Iron Overload in Patients With Thalassemia Major Condition: Thalassemia Iron Overload Date: 2011-07-11 Interventions: Drug: Amlodipine 5mg PO initially; may be reduced to 2.5mg PO if side effects |
Completed |
Study Name: Changes in Pituitary Iron and Volume With Deferasirox Condition: Iron Overload Date: 2011-06-17 |
Completed |
Study Name: Effects of Phlebotomy on Insulin Sensitivity in Insulin Resistance-associated Hepatic Iron Overload Patients Condition: Insulin Resistance Iron Overload Date: 2011-05-17 Interventions: Procedure: phlebotomy 7 ml/kg |
Completed |
Study Name: Open-Label Single-Arm Pilot Study in Adult Allogeneic Hematopoietic Stem Cell Transplant Recipients With Transfusional Iron Overload Condition: Iron Overload Date: 2011-03-30 Interventions: Drug: deferasirox Other Name: ICL670 |
Completed |
Study Name: Efficacy and Safety of Deferasirox in Combination With Deferoxamine Followed by Deferasirox Monotherapy in Severe Cardiac Iron Overload Condition: Cardiac Iron Overload Date: 2010-09-21 Interventions: Drug: Deferasirox and Deferoxamine |